Scott Applebaum is a high-impact, strategic executive with deep global experience and demonstrated operational success leading legal, commercial, and regulatory functions for small and large life sciences companies. Scott joins Context Therapeutics from Vitae Pharmaceuticals, where he was General Counsel & Corporate Secretary at the time of its sale to Allergan. Prior to Vitae, Scott was Chief Legal Officer & Corporate Secretary for Medgenics, Inc., a clinical stage, publicly traded biotech. Scott previously spent 10 years as Senior Vice President at Shire Pharmaceuticals, where he led the strategy and execution of three key functions – commercial, legal, and regulatory. Before joining Shire, Scott spent seven years in progressive legal positions at Bristol-Myers Squibb, and he began his career as an Associate in the Corporate Tax Department at Dechert LLP.
Scott earned a Juris Doctor from Stanford Law School, where he was an editor of the law review, and a B.S. in Economics from the Wharton School, University of Pennsylvania. He is a member of the Pennsylvania and New Jersey bars, and is a certified public accountant.